+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

False positive galactomannan Platelia due to piperacillin-tazobactam



False positive galactomannan Platelia due to piperacillin-tazobactam



Medecine et Maladies Infectieuses 42(1): 10-14



Invasive aspergillosis is a serious disease, the lethality of which is important among hematology patients. Early diagnosis is crucial for treatment options and the prognosis. Detection of the antigen galactomannan is the most frequently used microbiological tools. But galactomannan detection may be falsely positive, and this false positivity has been associated with piperacillin-tazobactam treatment, the main antibiotic combination used in clinical hematology. The purpose of our study, carried out from January 2009 to December 2010 at the Versailles hospital on in-patients with hematological disorders, was to evaluate the association between false galactomannan positivity and administration of piperacillin-tazobactam, and to study a possible variability of products issued by three manufacturers. We noted that 207 patients were included (n=207), accounting for 69 false positive and 138 true negative results. The intrinsic galactomannan values in the study were sensitivity 100%, specificity 68%, positive and negative predictive values respectively 16%, 100%, and a likelihood positive and negative test at respectively 3.12, and 0. The statistical analysis did not determine any association between false positivity in galactomannan and piperacillin-tazobactam issued by two manufacturers (P=0.87 and P=0.94). But, there was a significant association between false galactomannan positivity and piperacillin-tazobactam issued by the third manufacturer (P=0.02). Four of the 25 batches issued by this manufacturer were tested and negative "in vitro" for galactomannan. This study results suggest that the association between false galactomannan positivity and piperacillin-tazobactam is not longer systematic, but can still prevail depending on the manufacturers. It also confirmed the positive contribution of testing piperacillin-tazobactam batches "in vitro" before using the antibiotic.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053202924

Download citation: RISBibTeXText

PMID: 22153703

DOI: 10.1016/j.medmal.2011.10.018


Related references

False-positive results in the galactomannan Platelia™ Aspergillus assay with generic piperacillin/tazobactam. Revista Iberoamericana de Micologia 2019, 2019

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clinical Infectious Diseases 38(6): 913-916, 2004

False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?. Journal of Antimicrobial ChemoTherapy 62(5): 1109-1112, 2008

Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay. Journal of Antimicrobial ChemoTherapy 67(7): 1746-1748, 2012

False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Revista Iberoamericana de Micologia 24(2): 106-112, 2007

Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. Medical Mycology 55(5): 535-540, 2016

Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clinical Infectious Diseases 39(9): 1401-2; Author Reply 1402-3, 2004

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clinical Infectious Diseases 38(6): 917-920, 2004

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. Journal of Clinical Microbiology 52(6): 2199-2201, 2015

Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrobial Agents and ChemoTherapy 48(6): 1989-1992, 2004

Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study. European Journal of Clinical Microbiology and Infectious Diseases 34(7): 1437-1441, 2016

False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clinical and Vaccine Immunology 15(7): 1132-1133, 2008

Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum. Journal of Clinical Microbiology 45(9): 3141-3142, 2007

False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam--is it still an issue?. Diagnostic Microbiology and Infectious Disease 60(1): 117-120, 2007

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. New England Journal of Medicine 349(24): 2366-2367, 2003